marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q2
added 08-14-2024
Protalix BioTherapeutics Cash Flow 2011-2024 | PLX
Annual Cash Flow Protalix BioTherapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-1.32 M | -25 M | -10.3 M | -26.1 M | -19.4 M | -7.74 M | -9.99 M | -32.1 M | -24.3 M | -29.3 M | -30.7 M | 635 K | -23.6 M |
Depreciation & Amortization |
1.19 M | 1.09 M | 1.12 M | 1.3 M | 1.62 M | 1.67 M | 1.92 M | 1.98 M | 2.37 M | 3.14 M | 3.54 M | 3.69 M | - |
Accounts Payables |
19.6 M | 12.3 M | 16.4 M | 13.9 M | 11.9 M | 10.3 M | 9.31 M | 7.5 M | 5.53 M | 3.95 M | 5.25 M | 5.27 M | 5.03 M |
Accounts Receivables |
5.27 M | 4.59 M | 3.44 M | 2 M | 4.7 M | 4.73 M | 1.72 M | 693 K | - | 1.88 M | 2.09 M | 1.41 M | 1.37 M |
Total Inventories |
19 M | 16.8 M | 18 M | 13.1 M | 8.16 M | 8.57 M | 7.83 M | 5.24 M | 5.77 M | 6.67 M | 7.96 M | 4.04 M | 279 K |
All numbers in USD currency
Quarterly Cash Flow Protalix BioTherapeutics
| 2024-Q2 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | - | -3 M | - | -22.4 M | -13.2 M | -5.83 M | - | -5.2 M | -3.32 M | -9.83 M | - | -18.6 M | -15 M | -7.12 M | - | -15.7 M | -12.4 M | -7.28 M | - | -3.74 M | -17.4 M | -9.41 M | - | -27.6 M | -17 M | -8.43 M | - | -24.8 M | -21.3 M | -9.62 M | - | -20.4 M | -11.8 M | -6.42 M | - | - | - | - | - | - | - | -9.59 M | - | -1.19 M | 6.84 M | -6.28 M | - | -17 M | -8.81 M | -3.99 M |
Depreciation & Amortization |
- | - | - | 280 K | - | 811 K | 538 K | 270 K | - | 859 K | 574 K | 286 K | - | 1.01 M | 710 K | 376 K | - | 1.2 M | 784 K | 405 K | - | 1.26 M | 846 K | 430 K | - | 1.47 M | 986 K | 492 K | - | 1.49 M | 1.01 M | 516 K | - | 1.81 M | 1.22 M | 616 K | - | 2.42 M | 1.63 M | 828 K | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
19.3 M | 18.7 M | 18.5 M | 5.1 M | 12.3 M | 5.64 M | 6.99 M | 7.87 M | 6.99 M | 8.44 M | 6.13 M | 6.38 M | 13.9 M | 7.22 M | 7.22 M | 7.22 M | 11.9 M | 6.5 M | 6.5 M | 6.5 M | 10.3 M | 5.21 M | 5.21 M | 5.21 M | 9.31 M | 7.52 M | 7.52 M | 7.52 M | 7.5 M | 4.01 M | 4.01 M | 4.01 M | 5.53 M | 3.63 M | 3.63 M | 3.63 M | 6.8 M | 3.95 M | 3.95 M | 3.95 M | 5.25 M | 5.25 M | 5.25 M | 5.25 M | 5.27 M | 5.27 M | 5.27 M | 5.27 M | 5.03 M | 5.03 M | 5.03 M | 5.03 M |
Accounts Receivables |
10.1 M | 8.94 M | 4.05 M | 1.3 M | 4.59 M | 8.65 M | 2.02 M | 5.91 M | 3.44 M | 5.56 M | 2.33 M | 4.6 M | 2 M | 2 M | 2 M | 2 M | 4.7 M | 4.7 M | 4.7 M | 4.7 M | 4.73 M | 4.73 M | 4.73 M | 4.73 M | 1.72 M | 1.72 M | 1.72 M | 1.72 M | 693 K | 693 K | 693 K | 693 K | - | 4.57 M | - | 1.82 M | 1.88 M | 1.99 M | 1.88 M | 1.88 M | 2.09 M | 2.09 M | 2.09 M | 2.09 M | 1.41 M | 1.41 M | 1.41 M | 1.41 M | 1.37 M | 1.37 M | 1.37 M | 1.37 M |
Total Inventories |
20.7 M | 21.6 M | 19.6 M | 20.3 M | 16.8 M | 14.6 M | 16.5 M | 16.6 M | 18 M | 14.7 M | 13.6 M | 13.9 M | 13.1 M | 13.1 M | 13.1 M | 13.1 M | 8.16 M | 8.16 M | 8.16 M | 8.16 M | 8.57 M | 8.57 M | 8.57 M | 8.57 M | 7.83 M | 7.83 M | 7.83 M | 7.83 M | 5.24 M | 5.24 M | 5.24 M | 5.24 M | 5.77 M | 5.77 M | 5.77 M | 5.77 M | 3.45 M | 6.67 M | 6.67 M | 6.67 M | 7.96 M | 7.96 M | 7.96 M | 7.96 M | 4.04 M | 4.04 M | 4.04 M | 4.04 M | 279 K | 279 K | 279 K | 279 K |
All numbers in USD currency